Product Details:
| Minimum Order Quantity | 5000 Box |
| Strength | 625 mg |
| Packaging type | Box |
| Brand Name | MOXYLOC-CV 625 |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| FORM | TABLATS MONO |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Strength | 625 mg |
| Brand | AMOXIX -CV 625 TABLETS |
| Clavulanic Acid Content | 125 mg |
| Amoxicillin Content | 500 mg |
| Packaging Type | Alu Alu |
| Pack Size | 10 tablets |
| Usage | Human |
| Shelf Life | 24 months |
| Prescription | Prescription |
| Treatment | Bacterial Infection |
Product Details:
| Minimum Order Quantity | 5000 Box |
| Strength | 500 mg |
| Form | Capsule |
| Packaging Type | Box |
| Packaging Size | BLISTER 10*10 |
| Brand | MOXYLOC-500 |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 10000 Vial |
| Strength | 1.2 gm |
| Form | Injection |
| Packaging Type | Vial |
| Packaging Size | powder with water |
| Brand | MOXYLOC-1.2 G |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 5000 Box |
| Packaging Size | 10 Tablets |
| Brand | MOXYLOC-LB |
| Manufacturer | MEDLOCK HEALTHCARE |
| FORM | TABLETS MONO |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 5000 Bottle |
| Strength | 228.5 mg |
| Form | Syrup |
| Packaging Type | Bottle |
| Packaging Size | DRY SYRUP WITH WATER |
| Brand | MOXYLOC-CV |
| FROM | MEDLOCK HEALTHCARE |
Product Details:
| Minimum Order Quantity | 5000 Vial |
| Strength | 300 mg |
| Pack Size | Single Vial |
| Usage | Human |
| Brand | MOXYLOC-CV 300 |
| Packaging Type | Vial |
| Route | IV |
| Packaging Size | VIAL |
| Shelf Life | 24 months |
| Treatment | Skin Infection, Severe Infection, Respiratory Infection, Urinary Infection |
| Composition | Clavulanate, Amoxicillin |
| Form | Injection |
| FROM | MEDLOCK HEALTHCARE |
Moxyloc-CV 300 Injection is a potent antibiotic combination consisting of Amoxycillin, a broad-spectrum penicillin-type antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. This combination enhances Amoxycillin's effectiveness by preventing the breakdown of the antibiotic by certain bacterial enzymes, thus enabling it to act against a wider range of bacterial infections. Amoxycillin works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Clavulanic Acid protects it from resistance mechanisms.
Moxyloc-CV 300 Injection is used in the treatment of moderate to severe bacterial infections, especially those caused by beta-lactamase-producing bacteria. It is commonly prescribed for infections in the respiratory tract, urinary tract, skin, and soft tissues. Additionally, it is used in the treatment of intra-abdominal infections and bacterial infections that require intravenous antibiotic therapy.
Additional Information:
Product Details:
| Strength | 150 MG |
| Pack Size | Single Vial |
| Usage | Human |
| Brand | MOXYLOCK-CV-150 INJ |
| Packaging Type | Vial With WFI |
| Route | IV |
| Shelf Life | 24 months |
| Treatment | Severe Infection, Respiratory Infection, Skin Infection, Urinary Infection |
| Composition | Amoxicillin, Clavulanate |
| Form | Injection |
Moxyloc-150 Injection is a potent combination of amoxicillin and clavulanic acid, specifically formulated to combat various bacterial infections. Amoxicillin, a broad-spectrum penicillin antibiotic, works by inhibiting the growth of bacteria, while clavulanic acid serves as a beta-lactamase inhibitor, enhancing the effectiveness of amoxicillin against resistant strains. This synergistic formulation is designed for parenteral administration, ensuring rapid absorption and efficacy in treating a range of infections, including those affecting the respiratory tract, urinary system, skin, and soft tissues.
Moxyloc-150 is especially useful in cases where infections are caused by beta-lactamase producing bacteria that may otherwise resist treatment with amoxicillin alone. This makes it a vital option in clinical settings, particularly for patients who may be unable to tolerate oral medications due to severe illness or gastrointestinal complications.
The injection is typically administered under the supervision of a healthcare professional, ensuring proper dosing and monitoring for any potential reactions. Its formulation allows for precise dosage adjustments based on the severity of the infection and the patient’s overall health condition.